Indication
adult patients with acute myeloid leukaemia (AML) in first remission concomitantly treated with interleukin-2 (IL-2). The efficacy of Histamine dihydrochloride 0.5 mg/0.5 mL solution for injection has not been fully demonstrated in patients older than age 60.
Medicine details
- Medicine name:
- histamine dihydrochloride (Unknown)
- SMC ID:
- SMC2957
- Pharmaceutical company
- Brancaster Pharma Limited
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Resubmission
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC